Literature DB >> 12654604

Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.

Ramachandran S Vasan1, Lisa M Sullivan, Ronenn Roubenoff, Charles A Dinarello, Tamara Harris, Emelia J Benjamin, Douglas B Sawyer, Daniel Levy, Peter W F Wilson, Ralph B D'Agostino.   

Abstract

BACKGROUND: Experimental studies support a key role for cytokines in left ventricular remodeling. In congestive heart failure (CHF) patients, elevated plasma cytokine levels are associated with worse functional status and adverse prognosis. It is unclear whether cytokine levels can predict the incidence of CHF in asymptomatic individuals. METHODS AND
RESULTS: We investigated the relations of serum interleukin-6 (IL-6), C-reactive protein (CRP), and spontaneous production of tumor necrosis factor-alpha (TNFalpha) by peripheral blood mononuclear cell (PBMC) to CHF incidence among 732 elderly Framingham Study subjects (mean age 78 years, 67% women) free of prior myocardial infarction and CHF. On follow-up (mean 5.2 years), 56 subjects (35 women) developed CHF. After adjustment for established risk factors, including the occurrence of myocardial infarction on follow-up, there was a 60 (PBMC TNFalpha) to 68% (serum IL-6) increase in risk of CHF per tertile increment in cytokine concentration (P=0.04, and 0.03, respectively, for trend). A serum CRP level > or =5 mg/dL was associated with a 2.8-fold increased risk of CHF (P=0.02). Subjects with elevated levels of all 3 biomarkers (serum IL-6 and PBMC TNFalpha >median values, CRP> or =5 mg/dL) had a markedly increased risk of CHF (hazards ratio 4.07 [95% CI 1.34 to 12.37], P=0.01) compared with the other subjects.
CONCLUSIONS: In our elderly, community-based sample, a single determination of serum inflammatory markers, particularly elevated IL-6, was associated with increased risk of CHF in people without prior myocardial infarction. Additional epidemiological investigations are warranted to confirm the contribution of inflammation to the pathogenesis of CHF in the general population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654604     DOI: 10.1161/01.cir.0000057810.48709.f6

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  194 in total

Review 1.  Early detection of myocardial dysfunction and heart failure.

Authors:  Geoffrey de Couto; Maral Ouzounian; Peter P Liu
Journal:  Nat Rev Cardiol       Date:  2010-05-11       Impact factor: 32.419

2.  Fragility Fractures Are Associated with an Increased Risk for Cardiovascular Events in Women and Men with Rheumatoid Arthritis: A Population-based Study.

Authors:  Orla Ni Mhuircheartaigh; Cynthia S Crowson; Sherine E Gabriel; Veronique L Roger; L Joseph Melton; Shreyasee Amin
Journal:  J Rheumatol       Date:  2017-01-15       Impact factor: 4.666

3.  Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women.

Authors:  M Faraj; L Messier; J P Bastard; A Tardif; A Godbout; D Prud'homme; R Rabasa-Lhoret
Journal:  Diabetologia       Date:  2006-05-03       Impact factor: 10.122

4.  Diabetic cardiomyopathy in uncomplicated type 2 diabetes is associated with the metabolic syndrome and systemic inflammation.

Authors:  M Diamant; H J Lamb; J W A Smit; A de Roos; R J Heine
Journal:  Diabetologia       Date:  2005-06-30       Impact factor: 10.122

Review 5.  Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure.

Authors:  Kerry Wright; Cynthia S Crowson; Sherine E Gabriel
Journal:  Heart Fail Clin       Date:  2014-01-10       Impact factor: 3.179

6.  Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study.

Authors:  Catherine N Marti; Hassan Khan; Douglas L Mann; Vasiliki V Georgiopoulou; Kirsten Bibbins-Domingo; Tamara Harris; Annemarie Koster; Anne Newman; Stephen B Kritchevsky; Andreas P Kalogeropoulos; Javed Butler
Journal:  Circ Heart Fail       Date:  2013-12-09       Impact factor: 8.790

Review 7.  Role of Inflammation in Heart Failure.

Authors:  Lily F Shirazi; Joe Bissett; Francesco Romeo; Jawahar L Mehta
Journal:  Curr Atheroscler Rep       Date:  2017-06       Impact factor: 5.113

8.  Nitric oxide and promotion of cardiac myocyte apoptosis.

Authors:  Péter Andréka; Thanh Tran; Keith A Webster; Nanette H Bishopric
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

Review 9.  Trans fatty acids: effects on cardiometabolic health and implications for policy.

Authors:  R Micha; D Mozaffarian
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2008-11-08       Impact factor: 4.006

Review 10.  From pediatrics to geriatrics: Mechanisms of heart failure across the life-course.

Authors:  Kathleen C Woulfe; Danielle R Bruns
Journal:  J Mol Cell Cardiol       Date:  2018-11-17       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.